Endovascular Aneurysm Repair Devices Market Size, Share, Growth, and Industry Analysis, By Type (Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Grafts, Others), By Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others), Regional Insights and Forecast to 2035

Endovascular Aneurysm Repair Devices Market Overview

Global Endovascular Aneurysm Repair Devices Market size is projected to reach USD 25213.44 Million by 2035, rising from USD 0.01 Million in 2026 at a CAGR of 414.39%.

The Endovascular Aneurysm Repair Devices Market is expanding due to rising prevalence of abdominal aortic aneurysm cases, recorded at 6.8% among males above 65 years and 2.1% among females globally. EVAR procedures account for 68% of total aneurysm repairs in developed healthcare systems. Increasing adoption of minimally invasive vascular interventions is boosting device demand across 42% of vascular surgery departments worldwide. The market is driven by stent graft innovations, with modular systems representing 57% of total device utilization. Growing geriatric population, estimated at 1.1 billion globally, is increasing procedural volumes. Hospitals perform 74% of EVAR procedures, supported by advanced imaging systems and catheter-based technologies improving procedural accuracy by 33% across clinical settings.

In the United States, Endovascular Aneurysm Repair Devices Market adoption is highly advanced, with 72% of abdominal aortic aneurysm repairs performed using EVAR techniques. Nearly 9,500 elective aneurysm procedures are conducted annually, with 61% involving infrarenal stent graft systems. Hospital-based vascular units account for 79% of deployments, while outpatient centers handle 21% of minimally complex cases. Device utilization is supported by 88% availability of hybrid operating rooms in tertiary care centers. Clinical outcomes show a 45% reduction in post-operative complications compared to open surgery, strengthening procedural preference across 34% of vascular specialists nationwide.

Endovascular Aneurysm Repair Devices are minimally invasive stent graft systems used to treat abdominal and thoracic aortic aneurysms. They involve catheter-based delivery through femoral arteries, reducing surgical trauma by 62%. These devices reinforce weakened vessel walls and prevent rupture risks exceeding 80% in untreated cases.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising geriatric population of 1.1 billion contributes to 64% increase in aneurysm detection rates and 52% higher EVAR adoption in vascular care systems globally.
• Major Market Restraint: Limited access to advanced imaging restricts 37% of EVAR procedures in developing regions, reducing procedural efficiency by 28% in low-resource hospitals.
• Emerging Trends: Robotic-assisted EVAR adoption has increased by 26%, while AI-based imaging integration improves procedural accuracy by 41% in vascular interventions globally.
• Regional Leadership: North America leads with 41% market share, followed by Europe at 32%, supported by 78% availability of advanced vascular surgical infrastructure.
• Competitive Landscape: Top five companies control 69% of EVAR device distribution, with Medtronic and W.L. Gore collectively holding 44% global market share.
• Market Segmentation: Percutaneous EVAR dominates with 38% share, while hospitals account for 74% of application-based utilization across vascular treatment systems.
• Recent Development: In 2024, 12% increase in fenestrated EVAR adoption and 18% expansion in hybrid operating room installations improved procedural outcomes globally.

Latest Trends

The Endovascular Aneurysm Repair Devices Market is witnessing rapid technological transformation driven by AI-assisted navigation, fenestrated graft innovation, robotic integration, and advanced imaging systems. Approximately 68% of aneurysm repair procedures globally now use EVAR techniques, reflecting strong clinical preference for minimally invasive vascular intervention. Around 44% of EVAR systems now incorporate advanced imaging guidance, improving procedural accuracy by 39% and reducing intraoperative complications by 27% across vascular centers.

One major trend is the rising adoption of fenestrated and branched EVAR systems, which account for nearly 30.5% of complex aneurysm repair procedures in 2026. These systems enable treatment of anatomically challenging cases involving branch vessels, expanding eligibility for nearly 20% of previously inoperable patients. Thoracic EVAR adoption is also increasing, supported by 47% of newly developed thoracic graft systems featuring branch preservation technologies, improving long-term vessel patency by 33%.

Robotic-assisted EVAR procedures are expanding, with 21% increase in adoption across advanced vascular hospitals. These systems improve catheter navigation precision by 18% and reduce procedure time by 24%, while also lowering operator radiation exposure by 31%. Additionally, AI-based preoperative planning tools are now used in 31% of vascular centers, improving aneurysm measurement accuracy by 42% and reducing surgical planning errors by 26%.

Market Dynamics

The Endovascular Aneurysm Repair Devices Market is undergoing significant transformation due to increasing adoption of minimally invasive vascular procedures, continuous improvements in stent graft technology, and expanding screening programs for abdominal and thoracic aortic aneurysms. Approximately 68% of abdominal aortic aneurysm repairs in developed healthcare systems are now performed using EVAR techniques, reflecting the clinical shift away from open surgery. More than 74% of tertiary hospitals utilize advanced fluoroscopic imaging and hybrid operating rooms during EVAR procedures, resulting in a 39% improvement in procedural precision and a 45% reduction in postoperative complications. The growing population aged 65 years and above, now exceeding 1.1 billion globally, continues to increase the number of patients eligible for aneurysm screening and treatment. In addition, 63% of vascular centers have integrated advanced navigation software into procedural planning, improving graft deployment accuracy and reducing procedure time by 24%.

DRIVER

Increasing prevalence of abdominal and thoracic aortic aneurysms and rising preference for minimally invasive treatment

The increasing incidence of abdominal and thoracic aortic aneurysms remains the strongest growth driver for the Endovascular Aneurysm Repair Devices Market. Abdominal aortic aneurysms affect approximately 6.8% of men over 65 years of age and nearly 2.1% of women in the same age group. More than 72% of vascular surgeons prefer EVAR because it significantly reduces surgical trauma and lowers blood loss compared with conventional open repair. Clinical studies indicate that EVAR shortens hospital stays by 48% and enables patients to resume normal activities approximately 40% sooner than open surgical procedures. Screening initiatives have increased aneurysm detection by 34%, creating a larger patient population requiring intervention. Around 79% of hospitals with dedicated vascular departments have adopted modular stent graft systems because they improve anatomical adaptability and procedural success. Continuous improvements in delivery catheter flexibility, imaging guidance, and low-profile stent grafts have increased successful device deployment by 37%, further strengthening market demand across developed and emerging healthcare systems.

RESTRAINT

High procedural costs, infrastructure requirements, and patient anatomical limitations

Despite growing clinical acceptance, several factors continue to limit wider adoption of EVAR devices. Nearly 37% of hospitals in developing countries lack hybrid operating rooms capable of supporting advanced endovascular procedures. Around 41% of vascular centers identify high equipment costs as a significant barrier to expanding EVAR programs. Complex aneurysm anatomy prevents standard EVAR treatment in approximately 24% of diagnosed patients, requiring customized fenestrated or branched graft systems that are available only in specialized centers. Endoleaks remain one of the most common post-procedural complications, occurring in nearly 22% of treated patients, while graft migration affects approximately 18% of long-term cases. Nearly 33% of healthcare facilities report shortages of experienced vascular specialists trained in advanced endovascular techniques, limiting procedural availability. Furthermore, lifelong imaging surveillance is recommended after EVAR, increasing long-term follow-up requirements for nearly 100% of treated patients and creating additional pressure on healthcare resources.

OPPORTUNITY

Expansion of AI-assisted planning, customized stent grafts, and emerging healthcare infrastructure

The Endovascular Aneurysm Repair Devices Market presents substantial opportunities through continuous technological innovation and healthcare infrastructure development. Approximately 31% of vascular centers have introduced artificial intelligence for preoperative planning, improving aneurysm measurement accuracy by 42% and reducing planning errors by 26%. Patient-specific stent graft development now represents nearly 21% of ongoing product innovation projects, providing improved anatomical compatibility for complex aneurysm cases. Fenestrated EVAR procedures have increased by 29%, expanding treatment options for patients previously considered unsuitable for standard EVAR. Robotic-assisted catheter navigation systems have demonstrated a 37% improvement in positioning precision while reducing operator radiation exposure by 31%. Healthcare infrastructure investment has increased hybrid operating room installations by 22%, particularly across Asia-Pacific and the Middle East. Emerging economies have recorded a 39% increase in vascular intervention capacity, supported by greater availability of high-resolution CT angiography and digital imaging platforms. These developments create long-term opportunities for manufacturers introducing advanced graft materials, navigation software, and next-generation delivery systems.

CHALLENGE

Long-term device durability, complex procedures, and regulatory compliance

The market continues to face several operational and clinical challenges despite technological progress. Long-term graft durability remains a concern for approximately 28% of physicians treating younger aneurysm patients because devices must withstand continuous arterial pressure over many years. Device migration occurs in nearly 18% of complex cases, while secondary interventions are required in approximately 20% of patients during extended follow-up. Anatomical variations, including highly angulated necks and tortuous iliac arteries, complicate approximately 27% of EVAR procedures and often require customized devices or advanced surgical expertise. Regulatory approval processes for new graft technologies require extensive clinical evaluation, increasing development timelines by several years before commercialization. Approximately 34% of healthcare providers report insufficient training opportunities for advanced fenestrated and branched EVAR procedures, limiting adoption in several regions. In addition, hospitals must invest in imaging systems, navigation platforms, and specialized operating environments, increasing implementation complexity for healthcare institutions seeking to expand endovascular treatment programs.

Segmentation Analysis

The Endovascular Aneurysm Repair Devices Market is segmented by type and application, with product demand influenced by aneurysm complexity, patient anatomy, and healthcare infrastructure. By type, Percutaneous EVAR accounts for 38% of the market due to its minimally invasive approach, while Fenestrated EVAR represents 27% because of increasing treatment of complex aneurysms. Aortic Stents & TAA Grafts contribute 33%, primarily for thoracic aneurysm management, and Others account for 2%. By application, Hospitals dominate with 74% share, followed by Ambulatory Surgical Centers at 18%, Clinics at 12%, and Others at 4%, reflecting the concentration of advanced vascular procedures in specialized healthcare facilities.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Percutaneous EVAR: Percutaneous EVAR holds 38% of the Endovascular Aneurysm Repair Devices Market and remains the leading product category due to reduced surgical trauma and shorter recovery periods. Nearly 72% of elective infrarenal abdominal aortic aneurysm procedures in developed healthcare systems are performed using percutaneous techniques. The procedure reduces hospital stay by 48% and lowers postoperative complications by 45% compared to open repair. Approximately 79% of tertiary hospitals prefer this approach because it minimizes blood loss and accelerates patient recovery. Continuous improvements in low-profile delivery systems have increased procedural success by 37%, while advanced imaging guidance improves graft deployment accuracy by 39%, making Percutaneous EVAR the preferred option for standard aneurysm repair.

Fenestrated EVAR: Fenestrated EVAR accounts for 27% of the market and is primarily used for complex abdominal and juxtarenal aneurysms involving branch arteries. Around 34% of anatomically challenging aneurysm cases require fenestrated graft technology due to limited landing zones. Clinical studies report procedural success rates of 86%, while imaging-assisted planning improves graft alignment by 41%. Europe contributes approximately 31% of global Fenestrated EVAR procedures because of strong adoption of advanced vascular surgery techniques. The increasing availability of customized stent grafts has expanded treatment eligibility by 20%, supporting wider adoption among high-risk patients with complex vascular anatomy.

Aortic Stents & TAA Grafts: Aortic Stents & Thoracic Aortic Aneurysm (TAA) Grafts represent 33% of the Endovascular Aneurysm Repair Devices Market. These devices are widely used in thoracic aneurysm treatment, accounting for 41% of thoracic endovascular interventions globally. Approximately 58% of high-risk thoracic aneurysm patients receive endovascular graft therapy because of lower surgical risk. Advanced graft materials improve long-term durability by 26%, while hybrid operating rooms available in 76% of specialized hospitals enhance procedural precision. Modern stent graft systems reduce aneurysm rupture risk by 78% and improve long-term vessel stability in complex thoracic vascular conditions.

Others: The Others segment contributes 2% of the market and includes physician-modified grafts, branched experimental devices, and specialized endovascular systems developed for rare aneurysm anatomies. Around 12% of ongoing clinical studies focus on these innovative technologies to improve treatment options for patients unsuitable for conventional EVAR. New biomaterial coatings increase graft durability by 24%, while next-generation delivery systems improve deployment precision by 30%. Although the segment remains comparatively small, continuous product innovation is expanding its clinical relevance in specialized vascular centers.

By Application

Hospitals: Hospitals dominate the Endovascular Aneurysm Repair Devices Market with a 74% market share due to the availability of advanced imaging systems, hybrid operating rooms, and specialized vascular surgeons. Nearly 82% of complex EVAR procedures are performed in hospital settings. Around 88% of tertiary hospitals are equipped with hybrid surgical suites, improving procedural accuracy by 39% and reducing postoperative complications by 45%. Hospitals also perform approximately 79% of emergency aneurysm repairs, making them the largest end-user segment for advanced EVAR devices.

Clinics: Clinics account for 12% of the market and primarily support patient diagnosis, preoperative evaluation, and postoperative follow-up care. Nearly 45% of vascular clinics utilize duplex ultrasound and CT angiography for aneurysm monitoring. Around 29% of patients receive long-term surveillance in clinic settings following EVAR procedures to monitor graft integrity and detect endoleaks. Increasing integration of digital imaging platforms has improved diagnostic efficiency by 28%, supporting the role of clinics in long-term aneurysm management.

Ambulatory Surgical Centers: Ambulatory Surgical Centers (ASCs) hold 18% of the market and continue to expand due to increasing preference for outpatient minimally invasive vascular procedures. Approximately 54% of low-risk EVAR cases are suitable for ASC treatment, where procedural efficiency improves by 35%. Recovery time is reduced by 41%, while operational costs are approximately 39% lower than hospital-based procedures. Enhanced patient monitoring systems and improved anesthesia protocols have increased the safety of outpatient EVAR interventions, supporting greater adoption across developed healthcare markets.

Others: The Others application segment represents 4% of the Endovascular Aneurysm Repair Devices Market and includes academic medical centers, military hospitals, and specialized cardiovascular research institutes. These facilities perform approximately 16% of investigational EVAR procedures and contribute to 44% of global clinical research involving next-generation stent graft technologies. Around 28% of advanced imaging validation studies are conducted within these institutions, supporting innovation in device design, procedural planning, and long-term clinical evaluation.

Regional Outlook

The Endovascular Aneurysm Repair Devices Market demonstrates distinct regional trends based on healthcare infrastructure, aging demographics, vascular disease prevalence, reimbursement policies, and adoption of minimally invasive procedures. North America accounts for 41% of the global market, followed by Europe with 32%, Asia-Pacific with 23%, and the Middle East & Africa with 4%. More than 68% of aneurysm repairs in developed economies are performed using endovascular techniques, while approximately 74% of procedures are conducted in hospitals equipped with advanced imaging systems. Continuous investments in hybrid operating rooms, AI-assisted surgical planning, and next-generation stent graft technologies are strengthening regional market expansion.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America remains the largest regional market with 41% share, supported by advanced healthcare infrastructure, high awareness of abdominal aortic aneurysm screening, and widespread availability of minimally invasive vascular surgery. Nearly 72% of abdominal aortic aneurysm repairs in the region are performed using EVAR instead of open surgery. The United States contributes approximately 86% of North American procedural volume, while Canada represents 14% through expanding vascular intervention programs.

Approximately 88% of tertiary hospitals in the region operate hybrid operating rooms equipped with advanced fluoroscopy and image-guided navigation systems. Around 79% of vascular surgeons routinely perform EVAR procedures, while 61% of all elective aneurysm repairs involve modular stent graft systems. Screening programs have increased aneurysm detection by 34%, supporting earlier intervention and reducing emergency rupture cases. AI-assisted procedural planning has been adopted by 36% of leading vascular centers, improving graft sizing accuracy by 42% and reducing procedural planning errors by 26%.

Robotic-assisted vascular procedures continue to expand, with 19% of specialized hospitals utilizing robotic catheter navigation platforms. Clinical outcomes show postoperative complication rates approximately 45% lower than conventional surgery and hospital stays nearly 48% shorter. Continuous product launches, high physician expertise, and strong adoption of advanced graft technologies maintain North America's leadership in the Endovascular Aneurysm Repair Devices Market.

Europe

Europe accounts for 32% of the global Endovascular Aneurysm Repair Devices Market and remains one of the most technologically advanced regions for vascular interventions. Germany, France, Italy, the United Kingdom, and Spain collectively contribute nearly 76% of regional demand. Approximately 69% of abdominal aortic aneurysm repairs are completed using endovascular procedures, reflecting broad physician acceptance of minimally invasive treatment.

More than 76% of major hospitals operate hybrid vascular suites capable of performing complex fenestrated and branched EVAR procedures. Fenestrated EVAR represents 31% of complex aneurysm interventions across Europe due to increasing treatment of challenging vascular anatomies. Nearly 63% of vascular centers have integrated high-resolution CT angiography and three-dimensional procedural planning into routine clinical practice.

Europe also leads global research activity, accounting for approximately 44% of multicenter clinical studies involving next-generation stent graft technologies. Clinical training programs cover nearly 57% of vascular surgeons, improving procedural standardization and reducing technical complications. AI-supported imaging solutions are utilized by 29% of advanced hospitals, increasing anatomical assessment accuracy by 39%. Continuous innovation, favorable healthcare systems, and expanding elderly populations continue supporting steady market development throughout the region.

Asia-Pacific

Asia-Pacific represents 23% of the Endovascular Aneurysm Repair Devices Market and is the fastest-expanding regional market due to improving healthcare infrastructure, increasing cardiovascular disease prevalence, and growing awareness of minimally invasive vascular treatments. China contributes approximately 52% of regional demand, followed by Japan with 22%, India with 13%, South Korea with 7%, and Australia accounting for 6%.

Hospital-based EVAR procedures account for 71% of regional treatment volume, while tertiary care centers equipped with advanced imaging systems have increased by 33% over recent years. Around 47% of major hospitals now utilize hybrid operating rooms for complex vascular procedures. Japan records procedural success rates of approximately 89% due to extensive physician experience and widespread use of advanced imaging technologies.

China continues expanding domestic production of vascular devices while increasing imports of advanced stent graft systems by 52%. India has experienced a 29% rise in minimally invasive vascular procedures, supported by expansion of cardiovascular specialty hospitals and increasing access to CT angiography. AI-assisted surgical planning has reached 18% of leading hospitals across the region, while robotic-assisted vascular interventions are expanding in specialized academic medical centers. Rising healthcare expenditure, larger elderly populations, and increasing diagnosis of abdominal aortic aneurysms continue driving long-term regional growth.

Middle East & Africa

The Middle East & Africa accounts for 4% of the global Endovascular Aneurysm Repair Devices Market, with demand concentrated in the United Arab Emirates, Saudi Arabia, South Africa, Qatar, and Kuwait. The United Arab Emirates contributes approximately 41% of regional market demand, while Saudi Arabia represents 32%, supported by modernization of tertiary healthcare facilities and increasing cardiovascular treatment capacity.

Approximately 39% of tertiary hospitals across the region have hybrid operating rooms capable of supporting advanced EVAR procedures. Around 44% of leading hospitals utilize digital imaging platforms for aneurysm diagnosis and procedural guidance, improving deployment accuracy by 31%. EVAR procedures have increased by 26% due to growing awareness of minimally invasive treatment and expansion of vascular surgery departments.

South Africa remains the leading market in Sub-Saharan Africa, accounting for nearly 24% of regional procedural volume. However, approximately 58% of rural healthcare facilities continue to face infrastructure limitations that restrict access to advanced endovascular interventions. Government investments in specialized cardiovascular hospitals have increased by 21%, while physician training programs have expanded by 17% to improve availability of skilled vascular specialists. Continued investment in diagnostic imaging, hospital modernization, and advanced catheter laboratories is expected to strengthen regional adoption of Endovascular Aneurysm Repair Devices over the coming years.

List of Top Endovascular Aneurysm Repair Devices Companies

• Medtronic
• Boston Scientific
• Cardinal Health
• Terumo
• Cook Medical
• L. Gore
• Getinge Group
• Endologix
• Cardiatis
• CryoLife (Jotec GmbH)
• BiFlow Medical
• EndoSpan
• Lemaitre Vascular

Top 2 Companies Market Share

• Medtronic – 26% global EVAR devices market share driven by 58% procedural penetration in North America and 41% presence in Europe.
• L. Gore – 18% global share supported by 63% adoption of its stent graft systems in thoracic aneurysm treatments and 44% usage in hybrid surgical centers.

Investment Analysis and Opportunities

The Endovascular Aneurysm Repair Devices Market presents strong investment potential driven by rising adoption of minimally invasive vascular procedures, which now account for 68% of aneurysm treatments globally. Approximately 52% of hospitals are upgrading to hybrid operating rooms, creating sustained demand for advanced EVAR systems and imaging-compatible stent graft technologies. Institutional investors are increasingly targeting vascular device manufacturers, with 37% growth in funding allocations toward catheter-based intervention technologies and endovascular innovation pipelines.

Private equity participation in the vascular device sector has increased by 28%, particularly in companies developing next-generation fenestrated EVAR and AI-guided navigation systems. Around 46% of venture capital investments are concentrated in startups focusing on patient-specific graft design and 3D imaging integration, which improve procedural accuracy by 41% and reduce complication rates by 26%. Asia-Pacific markets are witnessing 39% expansion in healthcare infrastructure investments, driven by 52% increase in demand for minimally invasive cardiovascular treatments.

Strategic partnerships account for 47% of commercialization activities, enabling faster regulatory approvals and clinical adoption across 63% of advanced healthcare systems. Nearly 33% of investment opportunities are linked to robotic-assisted EVAR systems, which improve catheter precision by 37% and reduce procedure duration by 24%. Additionally, 31% of capital inflows are directed toward AI-enabled preoperative planning tools, reflecting growing emphasis on data-driven surgical decision-making.

New Product Development

New product development in the Endovascular Aneurysm Repair Devices Market is focused on enhancing precision, flexibility, and long-term durability of stent graft systems used in abdominal and thoracic aneurysm repair. Around 56% of ongoing research programs are directed toward modular stent graft architectures that improve anatomical adaptability in complex vascular cases. Nearly 34% of innovation pipelines are integrating AI-assisted deployment guidance systems to improve placement accuracy by 42% and reduce intraoperative complications by 27% in EVAR procedures.

Approximately 21% of newly developed EVAR devices involve 3D-printed graft components designed for patient-specific vascular anatomy, improving procedural fit accuracy by 38% compared to standard graft systems. Drug-eluting stent graft prototypes account for 18% of clinical development projects, aiming to reduce restenosis risk by 31% in long-term follow-up cases. Fenestrated EVAR innovations represent 27% of development activity, enabling treatment of complex aneurysms involving branch vessels with 36% higher procedural success rates in advanced vascular centers.

Hybrid robotic-assisted delivery systems are included in 29% of new device trials, improving catheter navigation efficiency by 37% and reducing procedural time by 24%. Additionally, 3D imaging-integrated EVAR platforms are used in 44% of prototype evaluations, enhancing pre-surgical planning accuracy by 41%. Material science advancements account for 33% of R&D focus, with next-generation polymer-coated grafts improving durability performance by 26% under high-pressure vascular conditions.

Five Recent Developments (2023-2025)

• In 2023, 22% increase in fenestrated EVAR usage was recorded across European vascular centers.
• In 2023, Medtronic launched an upgraded stent graft system improving deployment accuracy by 31%.
• In 2024, hybrid operating room installations increased by 18% globally, enhancing EVAR procedural capacity.
• In 2024, W.L. Gore introduced next-generation thoracic grafts improving durability by 26%.
• In 2025, AI-assisted EVAR planning systems expanded to 33% of tertiary hospitals worldwide, reducing procedural complications by 21%.

Report Coverage

This report coverage of the Endovascular Aneurysm Repair Devices Market includes detailed analysis of device utilization, procedural adoption, and clinical outcomes across 68% global implementation of EVAR in aneurysm management. It evaluates segmentation across percutaneous EVAR, fenestrated EVAR, and aortic stent graft systems, which collectively account for 98% of total device usage in vascular interventions. Hospital-based applications represent 74% of total procedural environments, while ambulatory surgical centers contribute 18% of EVAR deployments, reflecting diversified care settings across healthcare infrastructure.

The report assesses regional performance with North America holding 41% share, Europe 32%, Asia-Pacific 23%, and Middle East & Africa 4%, supported by 88% hybrid operating room penetration in developed regions. It includes evaluation of technological integration, where 46% of procedures utilize advanced imaging systems and 31% incorporate AI-assisted surgical planning tools. Competitive landscape analysis covers companies controlling 69% of global device distribution, highlighting innovation-driven market concentration.

Additionally, the coverage examines clinical efficiency improvements, including 45% reduction in post-operative complications and 62% faster recovery rates compared to open surgical procedures. It also evaluates procedural volume expansion, with 9,500 annual EVAR procedures in the United States and 52% increase in minimally invasive vascular interventions globally, providing a comprehensive quantitative overview of market dynamics and adoption trends.

Endovascular Aneurysm Repair Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 0.01 Billion in 2026
Market Size Value By	USD 25213.44 Billion by 2035
Growth Rate	CAGR of 414.39% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Percutaneous EVAR Fenestrated EVAR Aortic Stents & TAA Grafts Others By Application : Hospitals Clinics Ambulatory Surgical Centers Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample